Monday, September 14, 2026

Celltrion’s Breakthrough: Why Vegzelma and Herzuma Lead in Japan’s Oncology Market

Celltrion's cancer treatments dominate the Japanese market, with Vegzelma and Herzuma capturing significant shares, showcasing strong growth.

Foreign Tourists Visiting South Korea Nearing Pre-Pandemic Levels

The number of foreign tourists is recovering...

Foreign Health Insurance Enrollment Surges 28%: What This Means for Asia’s Healthcare Landscape

Foreign health insurance in the U.S. surged 28% to 1.68 million subscribers, showing a surplus of 2.8 trillion KRW over three years.

Tag: Roman Question

No posts to display

Top News

- Our Sponsors Ad -

Follow us